Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Surgery, Region Västra Götaland, NU-Hospital Group, Trollhättan, Sweden.
World J Surg. 2023 Jun;47(6):1570-1582. doi: 10.1007/s00268-023-06961-2. Epub 2023 Mar 1.
Laparoscopic lavage as a treatment for perforated diverticulitis, Hinchey III, has been found safe and feasible in randomized trials. A few studies have reported functional outcomes and quality of life as secondary outcomes. This study investigated distress associated with dysfunction of the bowel or stoma, functional outcomes, and quality of life 2-3 years after surgery in a national unselected cohort.
All patients in Sweden who underwent emergency surgery for perforated diverticulitis with purulent peritonitis (2016-2018) were invited to answer a comprehensive, study-specific questionnaire 2-3 years after the index surgery.
Out of 499 potential patients, 226 returned the questionnaire, and 209 were included in the analysis. There was no statistically significant difference between laparoscopic lavage and resection in distress associated with dysfunction of the bowel or stoma (odds ratio [OR], 1.32 [95% CI, 0.91-1.92]; p = 0.015). Bowel dysfunction measured by the LARS score was significantly higher for the lavage group (OR, 1.65 [95% CI, 1.11-2.45]), while stoma was more frequent after resection surgery (40 vs 6%).
Patients experienced long-term distress from bodily dysfunction after emergency surgery for perforated diverticulitis regardless of the technique used. Regular follow-up could benefit these patients.
The project was registered at ClinicalTrials.gov on 2017-11-06. Identifier: NCT03332550. Acronym: LapLav.
腹腔镜灌洗作为治疗穿孔性憩室炎(Hinchey III 级)的一种方法,在随机试验中已被证明是安全且可行的。一些研究报告了作为次要结果的功能结果和生活质量。本研究在全国非选择性队列中调查了手术后 2-3 年与肠道或造口功能障碍相关的痛苦、功能结果和生活质量。
邀请瑞典所有接受因化脓性腹膜炎而行穿孔性憩室炎急症手术的患者在指数手术后 2-3 年回答一份全面的、特定于研究的问卷。
在 499 名潜在患者中,有 226 名返回了问卷,其中 209 名被纳入分析。腹腔镜灌洗与切除术在与肠道或造口功能障碍相关的痛苦方面没有统计学上的显著差异(比值比 [OR],1.32 [95%置信区间,0.91-1.92];p=0.015)。LARS 评分测量的肠道功能障碍在灌洗组明显更高(OR,1.65 [95%置信区间,1.11-2.45]),而切除术后造口更常见(40%比 6%)。
无论采用何种技术,接受穿孔性憩室炎急症手术的患者在肠道功能障碍方面都经历了长期的痛苦。定期随访可能会使这些患者受益。
该项目于 2017 年 11 月 6 日在 ClinicalTrials.gov 上注册。标识符:NCT03332550。缩写:LapLav。